Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.


BACKGROUND Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked to obesity. Somatostatin (SST) and its analogs have been used to treat pediatric hypothalamic obesity. However, the application of such drugs for the treatment of NAFLD has not been evaluated. OBJECTIVE This study aimed to investigate the expression levels… (More)
DOI: 10.1371/journal.pone.0152085

8 Figures and Tables


  • Presentations referencing similar topics